台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    28.10
  • 漲跌
    ▼0.15
  • 漲幅
    -0.53%
  • 成交量
    739
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/11 ~ 2024/04/25     後一日»

券商獲利排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.80%1,715.91,7096.95502,1471,59728.528.129.228.1
  5.70%333.541.7291.810922912025.525.425.828.1
  3.56%196.534.3162.2135204692726.927.428.1
  4.23%131.2121.39.914111972827.428.628.1
  5.94%129.910.1119.87782526.726.528.628.1
  4.75%129.366.163.3-60359528.627.329.228.1
  3.17%128.4116.312.1461439728.327.82928.1
  10.59%115.6115.60039392826.529.428.1
  5.62%111.420.590.9-52146729.628.329.828.1
  6.67%100.255.644.530552527.326.628.828.1
  4.37%83.96716.9-23456828.227.328.828.1
  7.73%83.563.619.91040302726.128.228.1
  7.58%77.625.552.2-2963529.325.729.928.1
  4.34%7650.425.6-37256228.226.828.828.1
  8.01%74.245.428.8-1616322927.129.928.1
  3.02%7459.514.6-58308827.826.428.428.1
  2.51%72.263.68.671069927.226.927.528.1
  1.35%72.1072.1-188018828.5028.528.1
  2.31%71.9-1.673.5681154727272728.1
  1.40%69.80.169.7-1314217428.628.628.628.1
  2.85%6913.855.2-64208428.828.32928.1
  3.57%67.815.951.9-6066628.726.32928.1
  10.88%67.564.62.92222028.226.729.928.1
  6.23%67.142.324.9-22153828.426.429.228.1
  4.24%671156-41125429.328.529.428.1
  3.69%66.44521.4-41236428.126.728.628.1
  1.37%61.182-20.8-887316227.526.727.928.1
  6.11%60.928.332.619371826.926.42828.1
  2.85%60.251.29-19557528.227.628.528.1
  4.71%58.436.621.821452427.627.128.628.1
  2.44%56.337.119.216856927.126.927.428.1
  4.34%55.523.731.8-23204429.128.229.428.1
  1.85%55.357.3-2-198910827.727.42828.1
  3.93%55.118.436.741511027.527.229.128.1
  6.79%54.121.832.316301426.626.127.628.1
  8.44%52.913.739.11524826.125.727.428.1
  5.66%51.334.816.512332027.526.828.628.1
  1.79%50.656-5.440995928.628.229.228.1
  3.38%49.12821.121533227.427.12828.1
  4.19%48.120.327.9-28124028.727.429.128.1
  3.75%47.541.46.1-11344528.127.428.728.1
  0.71%45.183.7-38.6-12210723027.52727.828.1
  2.60%41.713.328.445581327.727.528.528.1
  4.07%41.234.76.5-11253628.127.328.728.1
  2.91%39.7039.74950027.327.326.728.1
  9.44%39.439.400151527.826.529.128.1
  4.60%36.435.60.80272828.327.628.928.1
  4.26%36.324.411.911312027.52728.228.1
  4.48%35.637.6-2-1283026.425.827.128.1
  4.10%35.217.517.7-18113028.627.42928.1

券商虧損排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.48%-408.5-69.8-338.7-1673920726.427.926.128.1
  -2.68%-397.26.9-404.1-4984654427.327.127.328.1
  -3.57%-273.2-95.5-177.7-12216328526.927.226.628.1
  -6.25%-196.7-188.8-7.9-129911128.329.327.428.1
  -5.39%-177.3-10.9-166.4104111729.629.728.128.1
  -6.27%-175.6-171.7-3.95100952828.927.128.1
  -2.48%-152.2-48.9-103.3-1645822227.628.327.528.1
  -5.76%-145.9-6.1-139.7-9329526.729.726.628.1
  -5.81%-128.8-26.9-101.9-60228326.727.726.428.1
  -1.46%-127-66.6-60.42233098628.228.427.628.1
  -5.09%-123-9.8-113.1-8469026.928.426.828.1
  -6.54%-99.9-64.5-35.3-23335627.328.526.628.1
  -3.62%-99.8-91.1-8.731996827.828.42728.1
  -3.25%-99.2-29.3-69.9-882311127.528.627.328.1
  -1.25%-89.4-25-64.4-6020326327.127.22728.1
  -0.94%-81.6-112.6313932028127.127.326.928.1
  -2.94%-80.8-79.8-19999027.828.227.328.1
  -4.51%-80.8-71.7-9-7576527.628.22728.1
  -3.39%-80.4-82.92.6488842727.526.528.1
  -6.39%-80.3-79.3-10444527.928.927.128.1
  -4.89%-80.1-72.5-7.65575128.729.427.928.1
  -5.79%-74-2.8-71.24243129.729.82728.1
  -2.47%-730.8-73.7-961210827.327.327.328.1
  -7.93%-70.3-67.3-3-1333426.127.125.128.1
  -0.20%-63.215.2-78.4-2958601,15627.827.827.828.1
  -4.92%-62.8-19.5-43.33344102929.427.428.1
  -1.82%-62.2-41.9-20.4-63581222828.527.828.1
  -0.22%-61.865.7-127.4-2907281,01827.627.627.728.1
  -5.88%-59.9-54.8-5.15363128.329.127.428.1
  -8.91%-53.8-44.6-9.2-5172227.428.926.328.1
  -4.30%-53.1-40.1-13-10344527.428.126.928.1
  -5.71%-51.2-50.5-0.7132312828.827.228.1
  -2.84%-50.4-56.4621654427.327.826.528.1
  -5.11%-48.8-46-2.9-4303428.128.927.428.1
  -5.99%-47.40.2-47.6-2823026.426.326.428.1
  -3.06%-44.9-1.7-43.2-4595427.227.327.128.1
  -3.32%-44.2-31.5-12.71046362929.428.528.1
  -2.98%-43.6-12.6-3138511328.728.927.928.1
  -9.56%-42.9-18.2-24.7-971726.428.225.628.1
  -3.77%-42.2-14.5-27.73039928.72927.428.1
  -6.75%-41.3-11-30.2-1672326.627.826.228.1
  -1.76%-41.1-43.32.1-28548228.52928.228.1
  -5.19%-40.7-36.8-3.8528222828.727.128.1
  -6.78%-40.6-40.600212128.529.427.528.1
  -3.74%-40.3-22.7-17.6-19193927.628.427.228.1
  -3.65%-39.1-32.1-711382728.228.727.628.1
  -2.31%-38.1-10.4-27.7-23376127.127.226.928.1
  -2.28%-37.7-11.5-26.246581228.528.727.728.1
  -3.77%-36.3-20.8-15.521341228.328.827.128.1
  -6.66%-36-7.3-28.7-11102125.726.225.528.1
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章